Coccidioidomycosis screening

Coccidioidomycosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes Coccidioides immitis Coccidioides posadasii
Differentiating Coccidioidomycosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Coccidioidomycosis screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Coccidioidomycosis screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Coccidioidomycosis screening
CDC on Coccidioidomycosis screening
Coccidioidomycosis screening in the news
Blogs on Coccidioidomycosis screening
Directions to Hospitals Treating Coccidioidomycosis
Risk calculators and risk factors for Coccidioidomycosis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Vidit Bhargava, M.B.B.S [2]; Aditya Ganti M.B.B.S. [3]

Overview

It is important to screen for Coccidioidomycosis in all cases of community acquired pneumonia in endemic areas.

Screening

Coccidioidomycosis is often mistaken for community acquired pneumonia(CAP) and this grossly underestimates the actual cases in the community. It is therefore important to screen for Coccidioidomycosis in all cases of community acquired pneumonia in endemic areas.